

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.96427723 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.96427723 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 7.96427723 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 7.96427723 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 7.96427723 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.96427723 |
| 7 | oligosaccharide catabolic process (GO:0009313) | 6.98982544 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.21230227 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.12744934 |
| 10 | amino sugar catabolic process (GO:0046348) | 5.79699421 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.79552194 |
| 12 | ceramide catabolic process (GO:0046514) | 5.61890283 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 5.39447477 |
| 14 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.31711523 |
| 15 | response to host immune response (GO:0052572) | 5.02141880 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.02141880 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 4.75647081 |
| 18 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.64631533 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.56225574 |
| 20 | response to host (GO:0075136) | 4.47484226 |
| 21 | response to host defenses (GO:0052200) | 4.47484226 |
| 22 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.47484226 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 4.46397357 |
| 24 | regulation of mononuclear cell migration (GO:0071675) | 4.41040279 |
| 25 | respiratory burst (GO:0045730) | 4.29617763 |
| 26 | membrane lipid catabolic process (GO:0046466) | 4.27813486 |
| 27 | sphingolipid catabolic process (GO:0030149) | 4.21874063 |
| 28 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.15623842 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 4.14270969 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 4.12360917 |
| 31 | response to peptidoglycan (GO:0032494) | 4.08584168 |
| 32 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.05852046 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05201297 |
| 34 | N-acetylneuraminate metabolic process (GO:0006054) | 4.04498324 |
| 35 | microglial cell activation (GO:0001774) | 3.98070009 |
| 36 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.98011419 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.97009643 |
| 38 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.96069996 |
| 39 | macrophage activation (GO:0042116) | 3.83288380 |
| 40 | phagosome maturation (GO:0090382) | 3.77904775 |
| 41 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.75752088 |
| 42 | granulocyte activation (GO:0036230) | 3.74607428 |
| 43 | barbed-end actin filament capping (GO:0051016) | 3.68922429 |
| 44 | regulation of cholesterol storage (GO:0010885) | 3.66667714 |
| 45 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.63280456 |
| 46 | natural killer cell mediated immunity (GO:0002228) | 3.63280456 |
| 47 | regulation of antigen processing and presentation (GO:0002577) | 3.62563869 |
| 48 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.62152872 |
| 49 | negative regulation of cell killing (GO:0031342) | 3.58282177 |
| 50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.58282177 |
| 51 | pinocytosis (GO:0006907) | 3.55614896 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.54982420 |
| 53 | low-density lipoprotein particle clearance (GO:0034383) | 3.54479595 |
| 54 | neutrophil activation (GO:0042119) | 3.53429521 |
| 55 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.53219535 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45924946 |
| 57 | protein localization to endosome (GO:0036010) | 3.45913012 |
| 58 | neutrophil mediated immunity (GO:0002446) | 3.45482070 |
| 59 | negative regulation of mast cell activation (GO:0033004) | 3.43605105 |
| 60 | regulation of monocyte chemotaxis (GO:0090025) | 3.39644196 |
| 61 | ganglioside metabolic process (GO:0001573) | 3.38733121 |
| 62 | regulation of macrophage chemotaxis (GO:0010758) | 3.38611482 |
| 63 | adhesion of symbiont to host cell (GO:0044650) | 3.38525753 |
| 64 | virion attachment to host cell (GO:0019062) | 3.38525753 |
| 65 | positive regulation of interferon-beta production (GO:0032728) | 3.36021970 |
| 66 | positive regulation of cholesterol efflux (GO:0010875) | 3.34356271 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 3.30572523 |
| 68 | melanin biosynthetic process (GO:0042438) | 3.30418950 |
| 69 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.29254888 |
| 70 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.27602689 |
| 71 | glucosamine-containing compound catabolic process (GO:1901072) | 3.25711433 |
| 72 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.22970763 |
| 73 | osteoclast differentiation (GO:0030316) | 3.22726575 |
| 74 | T-helper 1 type immune response (GO:0042088) | 3.22693877 |
| 75 | response to thyroid hormone (GO:0097066) | 3.22542565 |
| 76 | regulation of mast cell activation (GO:0033003) | 3.19561129 |
| 77 | negative regulation of interleukin-17 production (GO:0032700) | 3.17891749 |
| 78 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.17744076 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.16890219 |
| 80 | peptide catabolic process (GO:0043171) | 3.16842967 |
| 81 | I-kappaB phosphorylation (GO:0007252) | 3.14763425 |
| 82 | detection of molecule of bacterial origin (GO:0032490) | 3.13557735 |
| 83 | hyaluronan catabolic process (GO:0030214) | 3.12821689 |
| 84 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11112870 |
| 85 | positive regulation of leukocyte degranulation (GO:0043302) | 3.10033217 |
| 86 | monocyte chemotaxis (GO:0002548) | 3.09757587 |
| 87 | positive regulation of T cell apoptotic process (GO:0070234) | 3.09111428 |
| 88 | response to lipoprotein particle (GO:0055094) | 3.08584114 |
| 89 | regulation of leukocyte degranulation (GO:0043300) | 3.08450557 |
| 90 | lipoprotein transport (GO:0042953) | 3.07658221 |
| 91 | adhesion of symbiont to host (GO:0044406) | 3.07514152 |
| 92 | positive regulation of bone remodeling (GO:0046852) | 3.06871233 |
| 93 | positive regulation of bone resorption (GO:0045780) | 3.06871233 |
| 94 | glycosphingolipid catabolic process (GO:0046479) | 3.04418992 |
| 95 | response to muramyl dipeptide (GO:0032495) | 3.04132037 |
| 96 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.02621081 |
| 97 | intracellular pH reduction (GO:0051452) | 3.02608883 |
| 98 | lysosome organization (GO:0007040) | 3.01731980 |
| 99 | lytic vacuole organization (GO:0080171) | 3.01731980 |
| 100 | apoptotic cell clearance (GO:0043277) | 3.00208749 |
| 101 | melanin metabolic process (GO:0006582) | 3.00188728 |
| 102 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.99801949 |
| 103 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.97610487 |
| 104 | eosinophil chemotaxis (GO:0048245) | 2.96772405 |
| 105 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.96639766 |
| 106 | regulation of superoxide anion generation (GO:0032928) | 2.93722856 |
| 107 | glycosylceramide metabolic process (GO:0006677) | 2.90910491 |
| 108 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.90248012 |
| 109 | cell adhesion mediated by integrin (GO:0033627) | 2.89906207 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89658395 |
| 111 | negative regulation of lipid storage (GO:0010888) | 2.88893785 |
| 112 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.88731432 |
| 113 | positive regulation of B cell differentiation (GO:0045579) | 2.88585291 |
| 114 | regulation of integrin activation (GO:0033623) | 2.88294802 |
| 115 | bone resorption (GO:0045453) | 2.88062228 |
| 116 | positive regulation of heat generation (GO:0031652) | 2.87740317 |
| 117 | positive regulation of sterol transport (GO:0032373) | 2.85816582 |
| 118 | positive regulation of cholesterol transport (GO:0032376) | 2.85816582 |
| 119 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.85768302 |
| 120 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.85689161 |
| 121 | plasma lipoprotein particle clearance (GO:0034381) | 2.85222983 |
| 122 | vitamin D metabolic process (GO:0042359) | 2.85095933 |
| 123 | B cell mediated immunity (GO:0019724) | 2.84669278 |
| 124 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.84071828 |
| 125 | positive regulation of mast cell degranulation (GO:0043306) | 2.84071828 |
| 126 | mannose metabolic process (GO:0006013) | 2.83806675 |
| 127 | keratan sulfate catabolic process (GO:0042340) | 2.83512043 |
| 128 | defense response to protozoan (GO:0042832) | 2.82174859 |
| 129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81508248 |
| 130 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81508248 |
| 131 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81407602 |
| 132 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.80855570 |
| 133 | pH reduction (GO:0045851) | 2.79778146 |
| 134 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.78769293 |
| 135 | interaction with host (GO:0051701) | 2.78739529 |
| 136 | myeloid leukocyte activation (GO:0002274) | 2.77837303 |
| 137 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.76299493 |
| 138 | myeloid dendritic cell differentiation (GO:0043011) | 2.76177656 |
| 139 | basic amino acid transport (GO:0015802) | 2.72625310 |
| 140 | semaphorin-plexin signaling pathway (GO:0071526) | 2.70895974 |
| 141 | positive regulation of macrophage cytokine production (GO:0060907) | 2.69783788 |
| 142 | glycolipid catabolic process (GO:0019377) | 2.69019840 |
| 143 | neutrophil chemotaxis (GO:0030593) | 2.68235359 |
| 144 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.68107314 |
| 145 | low-density lipoprotein particle remodeling (GO:0034374) | 2.67594597 |
| 146 | pigment cell differentiation (GO:0050931) | 2.67354464 |
| 147 | glial cell migration (GO:0008347) | 2.67079195 |
| 148 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.67033331 |
| 149 | iron ion import (GO:0097286) | 2.65714665 |
| 150 | response to acidic pH (GO:0010447) | 2.64697453 |
| 151 | secondary metabolite biosynthetic process (GO:0044550) | 2.63013880 |
| 152 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.60400016 |
| 153 | detection of external biotic stimulus (GO:0098581) | 2.59484606 |
| 154 | lipid storage (GO:0019915) | 2.57283475 |
| 155 | phospholipid efflux (GO:0033700) | 2.56449570 |
| 156 | regulation of podosome assembly (GO:0071801) | 2.55614082 |
| 157 | detection of other organism (GO:0098543) | 2.54776571 |
| 158 | regulation of early endosome to late endosome transport (GO:2000641) | 2.54575586 |
| 159 | cellular response to arsenic-containing substance (GO:0071243) | 2.53733046 |
| 160 | regulation of vitamin metabolic process (GO:0030656) | 2.52532436 |
| 161 | transferrin transport (GO:0033572) | 2.50204908 |
| 162 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.49750722 |
| 163 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.49613844 |
| 164 | regulation of superoxide metabolic process (GO:0090322) | 2.47003288 |
| 165 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.46968263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.95014306 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.88600575 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.74297847 |
| 4 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.78470235 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.70452911 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.68918612 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.16958412 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31023705 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.22916724 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20534580 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75629635 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72393185 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.64300829 |
| 14 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.60978014 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.56930649 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56834754 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.54926305 |
| 18 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.35703913 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23843657 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18203465 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16210286 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13914441 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.05084843 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04976015 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99193076 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99181403 |
| 27 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99052273 |
| 28 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.95248863 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91568259 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87280639 |
| 31 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.84130414 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84030026 |
| 33 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.80134961 |
| 34 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.79744415 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79707123 |
| 36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72416321 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71530130 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70863250 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68356231 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64633387 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56062537 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52272033 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45116559 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44702009 |
| 45 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43682503 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40170965 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.38715242 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37386678 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35381925 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.35037797 |
| 51 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33316973 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.32507221 |
| 53 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29642660 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29040215 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28393816 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27714650 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27440829 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27365391 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27106611 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26999496 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22900892 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22166662 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22117544 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22016319 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20535732 |
| 66 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19622876 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19607718 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17703765 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17235662 |
| 70 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16406922 |
| 71 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15877053 |
| 72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14579713 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13804572 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13661519 |
| 75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13053911 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12615146 |
| 77 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12472787 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11164012 |
| 79 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10632477 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.10332740 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09835273 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09187202 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08645375 |
| 84 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08556555 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08031807 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07485431 |
| 87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07485431 |
| 88 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05907205 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05174219 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05055934 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04745925 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04500240 |
| 93 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03888869 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03827406 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03731985 |
| 96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03561899 |
| 97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03179481 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02921611 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02334807 |
| 100 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.99804013 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99246964 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98756426 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97538581 |
| 104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95948744 |
| 105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95811508 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95227376 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94436260 |
| 108 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92630370 |
| 109 | MYC_22102868_ChIP-Seq_BL_Human | 0.91893802 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91685789 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91489273 |
| 112 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90335282 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90335282 |
| 114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89222983 |
| 115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88820250 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87713757 |
| 117 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87143200 |
| 118 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86934488 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86838804 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86094471 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86008613 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85189986 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84117045 |
| 124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83046873 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81964611 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80090069 |
| 127 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80065466 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79478352 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76009263 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74485978 |
| 131 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74169731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 6.09910769 |
| 2 | MP0003172_abnormal_lysosome_physiology | 4.73657007 |
| 3 | MP0003303_peritoneal_inflammation | 4.34439198 |
| 4 | MP0000569_abnormal_digit_pigmentation | 4.19465475 |
| 5 | MP0006082_CNS_inflammation | 3.73376071 |
| 6 | MP0003436_decreased_susceptibility_to | 3.12850651 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.03717472 |
| 8 | MP0002419_abnormal_innate_immunity | 2.79944491 |
| 9 | MP0009840_abnormal_foam_cell | 2.79346668 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.71832961 |
| 11 | MP0000604_amyloidosis | 2.54839064 |
| 12 | MP0005174_abnormal_tail_pigmentation | 2.43142189 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.34543183 |
| 14 | MP0003690_abnormal_glial_cell | 2.33458104 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.22802982 |
| 16 | MP0010307_abnormal_tumor_latency | 2.18991830 |
| 17 | MP0004510_myositis | 2.17778509 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.07993230 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.05547769 |
| 20 | MP0001790_abnormal_immune_system | 2.04215008 |
| 21 | MP0005387_immune_system_phenotype | 2.04215008 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.03584278 |
| 23 | MP0005025_abnormal_response_to | 2.01599827 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 1.96187347 |
| 25 | MP0009785_altered_susceptibility_to | 1.91543714 |
| 26 | MP0003329_amyloid_beta_deposits | 1.86092935 |
| 27 | MP0003448_altered_tumor_morphology | 1.84722766 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.84697239 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.84451776 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.82174032 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.79961382 |
| 32 | MP0005451_abnormal_body_composition | 1.79179449 |
| 33 | MP0002723_abnormal_immune_serum | 1.74980603 |
| 34 | MP0004947_skin_inflammation | 1.72165612 |
| 35 | MP0001800_abnormal_humoral_immune | 1.71184299 |
| 36 | MP0001819_abnormal_immune_cell | 1.62543117 |
| 37 | MP0000371_diluted_coat_color | 1.61676714 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.60912108 |
| 39 | MP0006054_spinal_hemorrhage | 1.60451048 |
| 40 | MP0005310_abnormal_salivary_gland | 1.57383614 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.57289131 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.56275588 |
| 43 | MP0002405_respiratory_system_inflammati | 1.51430787 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.49558421 |
| 45 | MP0001958_emphysema | 1.48875205 |
| 46 | MP0000685_abnormal_immune_system | 1.48656625 |
| 47 | MP0009278_abnormal_bone_marrow | 1.42820448 |
| 48 | MP0003136_yellow_coat_color | 1.39050348 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.38691342 |
| 50 | MP0000343_altered_response_to | 1.36860076 |
| 51 | MP0003279_aneurysm | 1.36357953 |
| 52 | MP0002090_abnormal_vision | 1.35425813 |
| 53 | MP0004858_abnormal_nervous_system | 1.35324043 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.32295145 |
| 55 | MP0005671_abnormal_response_to | 1.31151310 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.30534958 |
| 57 | MP0003724_increased_susceptibility_to | 1.29246882 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.28522636 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.27822690 |
| 60 | MP0003075_altered_response_to | 1.25073173 |
| 61 | MP0008469_abnormal_protein_level | 1.24410152 |
| 62 | MP0001851_eye_inflammation | 1.23994207 |
| 63 | MP0000858_altered_metastatic_potential | 1.23714055 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.21758278 |
| 65 | MP0001542_abnormal_bone_strength | 1.17906982 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.16441086 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.14069348 |
| 68 | MP0000716_abnormal_immune_system | 1.13757559 |
| 69 | MP0005275_abnormal_skin_tensile | 1.13524526 |
| 70 | MP0005166_decreased_susceptibility_to | 1.09701899 |
| 71 | MP0002933_joint_inflammation | 1.07223333 |
| 72 | MP0005171_absent_coat_pigmentation | 1.06536069 |
| 73 | MP0004381_abnormal_hair_follicle | 1.06256260 |
| 74 | MP0003634_abnormal_glial_cell | 1.05165798 |
| 75 | MP0005365_abnormal_bile_salt | 1.05112196 |
| 76 | MP0005083_abnormal_biliary_tract | 1.04818711 |
| 77 | MP0005165_increased_susceptibility_to | 1.02111383 |
| 78 | MP0003950_abnormal_plasma_membrane | 1.00570229 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 0.98988667 |
| 80 | MP0002398_abnormal_bone_marrow | 0.98595220 |
| 81 | MP0003632_abnormal_nervous_system | 0.97173590 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.95915187 |
| 83 | MP0002722_abnormal_immune_system | 0.95040588 |
| 84 | MP0003091_abnormal_cell_migration | 0.93935472 |
| 85 | MP0000920_abnormal_myelination | 0.93253588 |
| 86 | MP0002429_abnormal_blood_cell | 0.92747836 |
| 87 | MP0010234_abnormal_vibrissa_follicle | 0.92688299 |
| 88 | MP0001545_abnormal_hematopoietic_system | 0.91550209 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 0.91550209 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 0.91082284 |
| 91 | MP0001853_heart_inflammation | 0.90945571 |
| 92 | MP0004883_abnormal_blood_vessel | 0.90662529 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 0.89580410 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.88924859 |
| 95 | MP0010155_abnormal_intestine_physiology | 0.88427395 |
| 96 | MP0005408_hypopigmentation | 0.87465356 |
| 97 | * MP0005257_abnormal_intraocular_pressure | 0.87441882 |
| 98 | MP0001186_pigmentation_phenotype | 0.85509256 |
| 99 | MP0002896_abnormal_bone_mineralization | 0.85289033 |
| 100 | MP0005390_skeleton_phenotype | 0.85198558 |
| 101 | MP0008260_abnormal_autophagy | 0.82468074 |
| 102 | MP0009764_decreased_sensitivity_to | 0.82067236 |
| 103 | MP0008004_abnormal_stomach_pH | 0.79218818 |
| 104 | MP0002254_reproductive_system_inflammat | 0.78583396 |
| 105 | MP0004130_abnormal_muscle_cell | 0.78437518 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.78238234 |
| 107 | MP0003795_abnormal_bone_structure | 0.78106070 |
| 108 | MP0003011_delayed_dark_adaptation | 0.75809386 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.75629627 |
| 110 | MP0005164_abnormal_response_to | 0.75343120 |
| 111 | * MP0005197_abnormal_uvea_morphology | 0.74233041 |
| 112 | MP0002166_altered_tumor_susceptibility | 0.74176450 |
| 113 | MP0010678_abnormal_skin_adnexa | 0.72763133 |
| 114 | MP0003828_pulmonary_edema | 0.67118141 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.66417268 |
| 116 | MP0001849_ear_inflammation | 0.64031603 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.62029561 |
| 118 | MP0000249_abnormal_blood_vessel | 0.62002660 |
| 119 | MP0009763_increased_sensitivity_to | 0.61901080 |
| 120 | MP0000490_abnormal_crypts_of | 0.61304139 |
| 121 | MP0002006_tumorigenesis | 0.60509174 |
| 122 | MP0002075_abnormal_coat/hair_pigmentati | 0.58542711 |
| 123 | MP0005023_abnormal_wound_healing | 0.58195733 |
| 124 | MP0000733_abnormal_muscle_development | 0.58191677 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.54870850 |
| 126 | MP0000598_abnormal_liver_morphology | 0.53212274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 8.33262286 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.67966030 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 6.63785817 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.88829757 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.62616310 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.62616310 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 5.62616310 |
| 8 | Dysostosis multiplex (HP:0000943) | 5.52393596 |
| 9 | Abnormality of macrophages (HP:0004311) | 5.13105907 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.94882714 |
| 11 | Mucopolysacchariduria (HP:0008155) | 4.94882714 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.81516873 |
| 13 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.77648049 |
| 14 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.77648049 |
| 15 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.77648049 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.69436448 |
| 17 | Disinhibition (HP:0000734) | 4.69221743 |
| 18 | Eczematoid dermatitis (HP:0000976) | 4.60286090 |
| 19 | Axonal loss (HP:0003447) | 4.52354258 |
| 20 | Loss of speech (HP:0002371) | 4.20871979 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.93993855 |
| 22 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.86753477 |
| 23 | J-shaped sella turcica (HP:0002680) | 3.24642394 |
| 24 | Agnosia (HP:0010524) | 3.24446149 |
| 25 | Nuclear cataract (HP:0100018) | 3.23776260 |
| 26 | Gingivitis (HP:0000230) | 3.19911477 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.15899179 |
| 28 | Myocardial infarction (HP:0001658) | 3.14122766 |
| 29 | Obstructive lung disease (HP:0006536) | 3.12439306 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.12439306 |
| 31 | Neuronal loss in central nervous system (HP:0002529) | 3.10571215 |
| 32 | Hepatosplenomegaly (HP:0001433) | 3.07360595 |
| 33 | Upper motor neuron abnormality (HP:0002127) | 3.03881230 |
| 34 | Global brain atrophy (HP:0002283) | 3.03074470 |
| 35 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.03069909 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.02441851 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.97347769 |
| 38 | Conjunctival telangiectasia (HP:0000524) | 2.89387612 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 2.88616420 |
| 40 | Recurrent skin infections (HP:0001581) | 2.74028295 |
| 41 | Diminished motivation (HP:0000745) | 2.73573767 |
| 42 | Apathy (HP:0000741) | 2.69840728 |
| 43 | Peripheral demyelination (HP:0011096) | 2.64985575 |
| 44 | Supranuclear gaze palsy (HP:0000605) | 2.62764192 |
| 45 | Stomatitis (HP:0010280) | 2.59067550 |
| 46 | Pathologic fracture (HP:0002756) | 2.57595608 |
| 47 | Myositis (HP:0100614) | 2.56994523 |
| 48 | Purpura (HP:0000979) | 2.56852508 |
| 49 | Inappropriate behavior (HP:0000719) | 2.56487338 |
| 50 | Abnormality of the lumbar spine (HP:0100712) | 2.49144334 |
| 51 | Skin nodule (HP:0200036) | 2.48779703 |
| 52 | Increased CSF protein (HP:0002922) | 2.48032993 |
| 53 | Thoracic kyphosis (HP:0002942) | 2.46398595 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.39833311 |
| 55 | Personality changes (HP:0000751) | 2.39514176 |
| 56 | Retinal atrophy (HP:0001105) | 2.36508307 |
| 57 | Orchitis (HP:0100796) | 2.35612946 |
| 58 | Dementia (HP:0000726) | 2.31414707 |
| 59 | Periodontitis (HP:0000704) | 2.29305403 |
| 60 | Bone pain (HP:0002653) | 2.28796884 |
| 61 | Prostate neoplasm (HP:0100787) | 2.24749975 |
| 62 | Mutism (HP:0002300) | 2.24636497 |
| 63 | Osteomyelitis (HP:0002754) | 2.22303916 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.20223372 |
| 65 | Xanthomatosis (HP:0000991) | 2.20014878 |
| 66 | Cardiomegaly (HP:0001640) | 2.18765057 |
| 67 | Metaphyseal irregularity (HP:0003025) | 2.17224754 |
| 68 | White forelock (HP:0002211) | 2.16552672 |
| 69 | Prolonged neonatal jaundice (HP:0006579) | 2.15049534 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.14071667 |
| 71 | Ovoid vertebral bodies (HP:0003300) | 2.13935174 |
| 72 | Frequent falls (HP:0002359) | 2.10776219 |
| 73 | Urticaria (HP:0001025) | 2.10751590 |
| 74 | Beaking of vertebral bodies (HP:0004568) | 2.09639017 |
| 75 | Ocular albinism (HP:0001107) | 2.09399158 |
| 76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09013355 |
| 77 | Cellulitis (HP:0100658) | 2.08847467 |
| 78 | Tetraparesis (HP:0002273) | 2.07060643 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.06225434 |
| 80 | Complement deficiency (HP:0004431) | 2.04543126 |
| 81 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.02757557 |
| 82 | Deformed sella turcica (HP:0002681) | 2.02753342 |
| 83 | Hypercholesterolemia (HP:0003124) | 2.01137258 |
| 84 | Neurodegeneration (HP:0002180) | 2.00438954 |
| 85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97872350 |
| 86 | Osteolytic defects of the hand bones (HP:0009699) | 1.97872350 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 1.97855683 |
| 88 | Retrobulbar optic neuritis (HP:0100654) | 1.97845096 |
| 89 | Optic neuritis (HP:0100653) | 1.97845096 |
| 90 | Patchy hypopigmentation of hair (HP:0011365) | 1.94787790 |
| 91 | Vertebral compression fractures (HP:0002953) | 1.93970000 |
| 92 | Thick nail (HP:0001805) | 1.93919036 |
| 93 | Glomerulonephritis (HP:0000099) | 1.93883487 |
| 94 | Mucosal telangiectasiae (HP:0100579) | 1.92604458 |
| 95 | Hematochezia (HP:0002573) | 1.90268668 |
| 96 | Protuberant abdomen (HP:0001538) | 1.88391642 |
| 97 | Poor head control (HP:0002421) | 1.88291635 |
| 98 | Abnormality of the thoracic spine (HP:0100711) | 1.87450326 |
| 99 | Epidermoid cyst (HP:0200040) | 1.86130301 |
| 100 | Spondylolisthesis (HP:0003302) | 1.84306845 |
| 101 | Pustule (HP:0200039) | 1.83060936 |
| 102 | Nausea (HP:0002018) | 1.81376639 |
| 103 | Premature loss of primary teeth (HP:0006323) | 1.80837871 |
| 104 | Joint hemorrhage (HP:0005261) | 1.79784024 |
| 105 | Vasculitis (HP:0002633) | 1.79281380 |
| 106 | Esophageal neoplasm (HP:0100751) | 1.78710632 |
| 107 | Neoplasm of head and neck (HP:0012288) | 1.78710632 |
| 108 | Cerebral inclusion bodies (HP:0100314) | 1.78710300 |
| 109 | Increased serum ferritin (HP:0003281) | 1.78464136 |
| 110 | Albinism (HP:0001022) | 1.77776389 |
| 111 | Absent frontal sinuses (HP:0002688) | 1.76842241 |
| 112 | Abnormality of complement system (HP:0005339) | 1.74433487 |
| 113 | Cervical subluxation (HP:0003308) | 1.73292698 |
| 114 | Spontaneous hematomas (HP:0007420) | 1.72236430 |
| 115 | Progressive visual loss (HP:0000529) | 1.71984012 |
| 116 | Abnormality of binocular vision (HP:0011514) | 1.71149270 |
| 117 | Diplopia (HP:0000651) | 1.71149270 |
| 118 | Recurrent viral infections (HP:0004429) | 1.70315697 |
| 119 | Multiple enchondromatosis (HP:0005701) | 1.68265104 |
| 120 | Generalized hypopigmentation (HP:0007513) | 1.68153604 |
| 121 | Abnormality of the periventricular white matter (HP:0002518) | 1.66631392 |
| 122 | Iris hypopigmentation (HP:0007730) | 1.66091629 |
| 123 | Spinal muscular atrophy (HP:0007269) | 1.60644700 |
| 124 | Pulmonary infiltrates (HP:0002113) | 1.58988249 |
| 125 | Multiple lipomas (HP:0001012) | 1.58964196 |
| 126 | Joint stiffness (HP:0001387) | 1.57453581 |
| 127 | Abnormality of the fovea (HP:0000493) | 1.57227909 |
| 128 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.56760151 |
| 129 | Amyloidosis (HP:0011034) | 1.56388365 |
| 130 | Polyneuropathy (HP:0001271) | 1.54927809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.98746252 |
| 2 | DDR2 | 3.97248881 |
| 3 | RIPK4 | 3.62847854 |
| 4 | GRK7 | 3.42262445 |
| 5 | TBK1 | 3.36820941 |
| 6 | ACVR1B | 3.01355463 |
| 7 | PDK2 | 2.83380733 |
| 8 | ERN1 | 2.70497756 |
| 9 | TRIB3 | 2.62191401 |
| 10 | IRAK3 | 2.50947589 |
| 11 | PKN2 | 2.49999406 |
| 12 | BLK | 2.49565187 |
| 13 | TYK2 | 2.45251987 |
| 14 | IRAK4 | 2.24488511 |
| 15 | NME2 | 2.23514285 |
| 16 | MAP3K14 | 2.23495821 |
| 17 | SCYL2 | 2.21788360 |
| 18 | TTN | 2.09630066 |
| 19 | MAP4K1 | 1.94122133 |
| 20 | CAMK1D | 1.91616381 |
| 21 | FES | 1.84230255 |
| 22 | TAOK3 | 1.81386711 |
| 23 | CSF1R | 1.68612592 |
| 24 | PBK | 1.66397452 |
| 25 | CDC42BPA | 1.66062733 |
| 26 | BMX | 1.64017265 |
| 27 | NEK9 | 1.62904062 |
| 28 | IKBKE | 1.62507200 |
| 29 | FGR | 1.60212739 |
| 30 | HCK | 1.58617083 |
| 31 | TAOK2 | 1.57545233 |
| 32 | TGFBR2 | 1.54868529 |
| 33 | PRPF4B | 1.51792505 |
| 34 | PDGFRA | 1.50303355 |
| 35 | IKBKB | 1.49336195 |
| 36 | JAK1 | 1.48433735 |
| 37 | SYK | 1.46928186 |
| 38 | PTK6 | 1.46442555 |
| 39 | MAP3K13 | 1.40399811 |
| 40 | TGFBR1 | 1.39291453 |
| 41 | ADRBK2 | 1.38070403 |
| 42 | MST1R | 1.36772603 |
| 43 | ZAP70 | 1.35299370 |
| 44 | CAMKK2 | 1.34822650 |
| 45 | CAMK1G | 1.34635635 |
| 46 | ABL2 | 1.32919148 |
| 47 | RIPK1 | 1.32879298 |
| 48 | BMPR2 | 1.30295760 |
| 49 | CSK | 1.26597531 |
| 50 | JAK3 | 1.26445315 |
| 51 | EPHB1 | 1.24048063 |
| 52 | PAK4 | 1.15401848 |
| 53 | JAK2 | 1.12743260 |
| 54 | SIK2 | 1.12514456 |
| 55 | LCK | 1.11607912 |
| 56 | LYN | 1.09135209 |
| 57 | MARK3 | 1.07079126 |
| 58 | MAP2K3 | 1.06999717 |
| 59 | LRRK2 | 1.06734606 |
| 60 | CAMKK1 | 1.03815848 |
| 61 | EGFR | 1.00964710 |
| 62 | LATS2 | 0.97893576 |
| 63 | CDK12 | 0.97572656 |
| 64 | TRPM7 | 0.93974108 |
| 65 | STK10 | 0.89911566 |
| 66 | ABL1 | 0.89007575 |
| 67 | KSR2 | 0.88826163 |
| 68 | MAP3K3 | 0.87687165 |
| 69 | RPS6KA4 | 0.87094604 |
| 70 | PIM2 | 0.85951369 |
| 71 | CDK6 | 0.85909929 |
| 72 | BTK | 0.85680889 |
| 73 | TAOK1 | 0.83399288 |
| 74 | MOS | 0.83226842 |
| 75 | MAPK7 | 0.83137711 |
| 76 | STK24 | 0.78879459 |
| 77 | MAP2K6 | 0.78867126 |
| 78 | MAPK12 | 0.76499113 |
| 79 | SIK3 | 0.76387953 |
| 80 | CHUK | 0.75763517 |
| 81 | PRKCH | 0.74536749 |
| 82 | LIMK1 | 0.73954317 |
| 83 | MAPKAPK3 | 0.73404802 |
| 84 | PRKCD | 0.69058269 |
| 85 | FER | 0.67835476 |
| 86 | ITK | 0.67810534 |
| 87 | MATK | 0.67141672 |
| 88 | FYN | 0.64837336 |
| 89 | MAP3K5 | 0.64758247 |
| 90 | MAP3K6 | 0.64202633 |
| 91 | MAP3K11 | 0.63208071 |
| 92 | IRAK2 | 0.60387335 |
| 93 | ERBB4 | 0.60286123 |
| 94 | PDPK1 | 0.58432183 |
| 95 | TESK1 | 0.57360895 |
| 96 | ARAF | 0.57153599 |
| 97 | TESK2 | 0.55402221 |
| 98 | GRK6 | 0.54647043 |
| 99 | MYLK | 0.53899391 |
| 100 | MAP3K9 | 0.53692538 |
| 101 | TXK | 0.52830341 |
| 102 | PDGFRB | 0.51682085 |
| 103 | PRKD1 | 0.51037012 |
| 104 | SRC | 0.47721103 |
| 105 | TEC | 0.47586233 |
| 106 | DAPK2 | 0.47199039 |
| 107 | PIM1 | 0.46713192 |
| 108 | ALK | 0.45954938 |
| 109 | MAP3K2 | 0.45278592 |
| 110 | PDK1 | 0.45089934 |
| 111 | GSK3A | 0.43478638 |
| 112 | IRAK1 | 0.43456091 |
| 113 | MAPK4 | 0.43295731 |
| 114 | RPS6KL1 | 0.43285693 |
| 115 | RPS6KC1 | 0.43285693 |
| 116 | ICK | 0.40721021 |
| 117 | FGFR3 | 0.40419581 |
| 118 | STK4 | 0.39898781 |
| 119 | EPHA3 | 0.39705481 |
| 120 | MAP3K1 | 0.38950082 |
| 121 | PRKAA2 | 0.38557178 |
| 122 | PAK6 | 0.37582190 |
| 123 | DAPK3 | 0.37342827 |
| 124 | RPS6KA2 | 0.37143823 |
| 125 | NEK6 | 0.37025440 |
| 126 | STK3 | 0.35162522 |
| 127 | INSR | 0.34213513 |
| 128 | TYRO3 | 0.31987341 |
| 129 | PRKG2 | 0.31707965 |
| 130 | RET | 0.29429972 |
| 131 | PTK2B | 0.29344756 |
| 132 | MAP3K8 | 0.29320056 |
| 133 | IGF1R | 0.27494149 |
| 134 | MAP3K10 | 0.26950450 |
| 135 | PLK2 | 0.26003425 |
| 136 | SGK3 | 0.25824659 |
| 137 | MAPKAPK2 | 0.25348930 |
| 138 | PAK2 | 0.24165463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.69325971 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 4.49393078 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.93813791 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81320020 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61349729 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54621021 |
| 7 | Phagosome_Homo sapiens_hsa04145 | 2.46430341 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.35798088 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.33884459 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23959327 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.23259655 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.21060602 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.97300054 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.85371279 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.75867617 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74701177 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73199108 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65678957 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61271254 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56423781 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.49863950 |
| 22 | Apoptosis_Homo sapiens_hsa04210 | 1.47764624 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.45822949 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.41772509 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35041615 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34790535 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34534584 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33603562 |
| 29 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31203612 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.29687675 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28329912 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27081680 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26006170 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25809613 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.24500756 |
| 36 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24287308 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21536553 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19754109 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.16738042 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13697358 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08438103 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08396677 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98914626 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 0.96414184 |
| 45 | Asthma_Homo sapiens_hsa05310 | 0.95978330 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90720332 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.90560959 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90107005 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89933878 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89636318 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89352604 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83715006 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.83563529 |
| 54 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82170594 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81097977 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80501031 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79055500 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.78927294 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78054300 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77798199 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77730715 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76111014 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.75386564 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74628708 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74170080 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73692314 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72330104 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70588125 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.69616753 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 0.69526174 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68278286 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66836453 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.66485260 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65897687 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64862657 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64606938 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.64391669 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62537540 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62059224 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61718070 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60586474 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60004071 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58377739 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53687123 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53537336 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52045386 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51626898 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.51396601 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50142151 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47809569 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45671858 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45497411 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43577084 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43315241 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42959591 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41701067 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41674357 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39739331 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39541218 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35778558 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.34831125 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34464608 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33155998 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.31773505 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31091988 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29734247 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29603476 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27458168 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.27079252 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26830636 |
| 111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26523227 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25787047 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25341923 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24522356 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23686961 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19751624 |

